Alogliptin-d 3

Overview

Alogliptin-d 3 is the deuterium labeled Alogliptin. Alogliptin (SYR-322 free base) is a potent, selective and orally active inhibitor of DPP-4 with an IC 50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9 . Alogliptin can be used for the research of type 2 diabetes.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Dipeptidyl Peptidase | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-A0023AS1
• CAS No.: 1133421-35-8
• Molecular Formula: C18H18D3N5O2
• Molecular Weight: 342.41
• Purity: 99.61%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source